Comparison of the Effectiveness of Two Psycho-physical Interventions: Mindfulness Based Relapse Prevention (MBRP) and Unguided Meditative Relaxation in Patients With Alcohol Use Disorder
Key facts
- Who runs it
- Centre Hospitalier Universitaire de Nīmes
- Where
- France7 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 168 people, planned
- Started
- 20 Oct 2021
- Expected to end
- Jan 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Mindfulness Based Relapse Prevention
- Relaxation/ meditation
- Record updated
- 21 August 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Having a moderate to severe alcohol use disorder according to DSM 5 criteria
- The last drink must have been consumed at most in the last 60 days before the pre-inclusion visit. The patient must have had at least 1 HDD during the last drinking period
Who cannot take part
- Other mindfulness-based structured therapies
- Schizophrenic disorder,
- Patient with dementia or severe cognitive impairment that would prevent him/her from following the course of a session, as judged by the clinician
- Severe depression (Beck Depression Inventory> 30)
- Current maniac or hypomaniac episode,
- Insufficient French understanding to complete the questionnaires
- Pregnant or breastfeeding woman
- Absence of social security regimen
- Refusal to sign the written consent. • The patient is under safeguard of justice or state guardianship
This trial is currently available in France.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Alcohol use disorder (AUD) is the second highest preventable cause of death in France. Only 3% of patients are prescribed approved drugs for reducing alcohol consumption or maintenance of abstinence. Increasing evidence supports the efficacy of psychotherapies such as cognitive and behavioral therapies (CBT) in AUD. However, some patients are resistant to CBT and the positive effects of CBT could wane over time, resulting in mid- and long-term relapses. Mindfulness practice is increasingly widespread in the United States and its efficacy in various fields appears very promising. The study investigators hypothesize that the Mindfulness Based Relapse Prevention (MBRP) program will be more efficient than a relaxation/meditation without guidance control program in AUD.
The 2 groups in the trial
- MBRP program:Treatment being tested
Treatment: Mindfulness Based Relapse Prevention
- Standard careExisting treatment, for comparison
Treatment: Relaxation/ meditation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 21 August 2025